Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


BioFire Diagnostics Inc.

Division of Institut Merieux

Latest From BioFire Diagnostics Inc.

Summit Looking To Secure Superiority Claim For Ridinilazole Over Vancomycin In C. Diff

Company’s Phase III program is attempting to replicate Phase II efficacy data showing superiority for curing Clostridium difficile infections and preventing recurrence, while also compiling health economics data.

Clinical Trials Research and Development Strategies

US Approvals Analysis: Molecular Dx Innovations Make Waves In November

Four novel molecular diagnostics, including two next-generation sequencing platforms, gained FDA approval in November, almost half of the nine novel-device approvals last month. The agency was also active with PMA supplement approvals and 510(k) clearances during the period.

Approvals Research and Development Strategies

STAT-DX Aims To Take On Rival BioFire In Syndromic Testing

Barcelona start-up STAT-DX is gearing up to launch a new decentralized multiplex PCR system in the rapidly growing field of syndromic testing. The company, which will face larger rivals such as bioMérieux's BioFire, will unveil its new point-of-care platform at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), in Vienna from 22-25 April.

Infectious Diseases In Vitro Diagnostics

US Approvals Analysis: Strong Month For IVD De Novos In February

FDA's increasingly popular de novo classification pathway for moderate-risk devices that have no predicate accounted for five marketing go-aheads last month, four of which were for in vitro diagnostics.

In Vitro Diagnostics Cardiology
See All

Company Information

  • Industry
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
  • Research, Analytical Equipment & Supplies
    • PCR & Amplification Tools
  • Therapeutic Areas
  • Infectious & Viral Diseases
  • Alias(es)
  • Idaho Technology Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Institut Merieux
  • Senior Management
  • Kirk Ririe, CEO
    Robert J Lollini, CFO & Treasurer
    Randy Rasmussen, Pres. & COO
    Rachel Jones, SVP, Sales & Mktg.
    de Silva Deepika, SVP. Biochemistry
  • Contact Info
  • BioFire Diagnostics Inc.
    Phone: (801) 736-6354
    390 Wakara Way
    Salt Lake City, UT 84108